 At Visit 1 Screening and vaccination visit, written informed consent is obtained and the subjects eligibility is assessed according to the pre-specified in-exclusion criteria, including measurement of oral temperature. If the subject is included, a pre-vaccination blood sample is taken for polio antibody determinations, and the subject is randomly allocated into one of the 4 groups to be vaccinated. 